Elanco Animal Health Shares Sink On Unexpected Label Update For Canine Dermatology Drug

Loading... Elanco Animal Health Incorporated ELAN stock is tumbling as the company released updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro. For the minor technical section for labeling, earlier this week, the company aligned with the FDA on the language and expects to receive the completion letter by mid-July. "However, we expect the U.S. label will include a boxed warning on safety based on the outcome of a trial with unvaccinated dogs dosed at 3x the label dose," said Bob ...